{"schema_version":"secwatch.filing_event.v1","accession":"0001401914-23-000042","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2023-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.797661+00:00","generated_at":"2026-06-13T04:53:07.330090+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Daré Bioscience receives Nasdaq deficiency notice for bid price below $1.00; has until Jan 16, 2024 to regain compliance","bullets":["Received Nasdaq letter on July 19, 2023, for failing Minimum Bid Price Requirement over 30 consecutive business days.","Has 180 calendar days (until Jan 16, 2024) to regain compliance by closing at $1.00+ for 10 consecutive days.","If not, may be eligible for additional 180-day period if meeting other listing standards.","Cannot assure compliance; considering options including reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001401914-23-000042","json":"https://secwatch.observer/filing/0001401914-23-000042.json","markdown":"https://secwatch.observer/filing/0001401914-23-000042.md","text":"https://secwatch.observer/filing/0001401914-23-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/0001401914-23-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/dare-20230719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:53:07.330090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d0294229de9d35057df70257d1bd5689cefdc91","claim":"Dare Bioscience, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"July 19, 2023, Daré Bioscience, Inc. (“Daré”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Daré that, for the last 30 consecutive business days, the closing bid price for Daré’s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq letter has no immediate effect on the listing of Daré’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq listing","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/0001401914-23-000042-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}